New structural insights pave the way for drug-resistant malaria therapies

Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.

Related Keywords

Huilin Li ,Laura Kirkman ,Sanders Tri ,Hao Chi Hsu ,Van Andel Institute ,Rockefeller University ,Nature Communications ,Institutional Therapeutics Discovery Institute Tri ,Memorial Sloan Kettering Cancer Center ,World Health Organization ,Weill Cornell Medicine ,Van Andel ,Gang Lin ,Weill Cornell ,Structural Biology ,Enterprise Innovation ,Drugs ,Malaria ,Animal Model ,Compound ,Electron ,Electron Microscopy ,Maging ,Mmunology ,Medicine ,Icrobiology ,Icroscopy ,Olecule ,Utation ,Plasmodium Falciparum ,Reclinical ,Research ,Herapeutics ,